Adverse events according to glucocorticoid induction regimen
| Total | 1A | 1B | |
| Total number (%) of participants with an SAE | 27 (14.3) | 10 (18.5) | 17 (12.7) |
| Total number (%) of participants with a serious infection | 7 (3.7) | 0 | 7 (5.2) |
| Total number (%) of participants with a non-serious infection | 59 (31.4) | 12 (22.2) | 47 (35.1) |
| Number (%) of participants with IgG <5 g/L | 51 (27.1) | 27 (50.0) | 24 (25.4) |
1A: higher dose glucocorticoid induction regimen, starting at 1 mg/kg/day (maximum starting dose 60 mg/day); 1B: lower dose glucocorticoid induction regimen, starting at 0.5 mg/kg/day (maximum starting dose 30 mg/day).
SAE, serious adverse event.